nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—Ageusia—Beclomethasone—psoriasis	0.042	0.042	CcSEcCtD
Methylscopolamine bromide—Ageusia—Acitretin—psoriasis	0.0261	0.0261	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Calcipotriol—psoriasis	0.0157	0.0157	CcSEcCtD
Methylscopolamine bromide—Ageusia—Mycophenolate mofetil—psoriasis	0.0135	0.0135	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Calcitriol—psoriasis	0.0133	0.0133	CcSEcCtD
Methylscopolamine bromide—Mydriasis—Prednisolone—psoriasis	0.0128	0.0128	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Acitretin—psoriasis	0.0122	0.0122	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Beclomethasone—psoriasis	0.0121	0.0121	CcSEcCtD
Methylscopolamine bromide—Tension—Methoxsalen—psoriasis	0.0114	0.0114	CcSEcCtD
Methylscopolamine bromide—Nervousness—Methoxsalen—psoriasis	0.0113	0.0113	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Clobetasol propionate—psoriasis	0.00983	0.00983	CcSEcCtD
Methylscopolamine bromide—Urticaria—Beclomethasone—psoriasis	0.00965	0.00965	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Hydroxyurea—psoriasis	0.00927	0.00927	CcSEcCtD
Methylscopolamine bromide—Tension—Acitretin—psoriasis	0.00905	0.00905	CcSEcCtD
Methylscopolamine bromide—Nervousness—Acitretin—psoriasis	0.00896	0.00896	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fluocinonide—psoriasis	0.00887	0.00887	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Mycophenolic acid—psoriasis	0.00877	0.00877	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Acitretin—psoriasis	0.0087	0.0087	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Fluocinolone Acetonide—psoriasis	0.00867	0.00867	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Calcitriol—psoriasis	0.00864	0.00864	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methoxsalen—psoriasis	0.00859	0.00859	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Calcitriol—psoriasis	0.00846	0.00846	CcSEcCtD
Methylscopolamine bromide—Headache—Clobetasol propionate—psoriasis	0.00836	0.00836	CcSEcCtD
Methylscopolamine bromide—Dizziness—Beclomethasone—psoriasis	0.00803	0.00803	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Mycophenolic acid—psoriasis	0.00802	0.00802	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fluocinonide—psoriasis	0.00796	0.00796	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methoxsalen—psoriasis	0.00783	0.00783	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Acitretin—psoriasis	0.00768	0.00768	CcSEcCtD
Methylscopolamine bromide—Insomnia—Calcitriol—psoriasis	0.00766	0.00766	CcSEcCtD
Methylscopolamine bromide—Headache—Beclomethasone—psoriasis	0.00761	0.00761	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methoxsalen—psoriasis	0.00754	0.00754	CcSEcCtD
Methylscopolamine bromide—Headache—Fluocinonide—psoriasis	0.00754	0.00754	CcSEcCtD
Methylscopolamine bromide—Somnolence—Calcitriol—psoriasis	0.00753	0.00753	CcSEcCtD
Methylscopolamine bromide—Constipation—Calcitriol—psoriasis	0.00724	0.00724	CcSEcCtD
Methylscopolamine bromide—Nausea—Beclomethasone—psoriasis	0.00721	0.00721	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Cyclosporine—psoriasis	0.00709	0.00709	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methoxsalen—psoriasis	0.007	0.007	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Mycophenolate mofetil—psoriasis	0.00692	0.00692	CcSEcCtD
Methylscopolamine bromide—Insomnia—Acitretin—psoriasis	0.00681	0.00681	CcSEcCtD
Methylscopolamine bromide—Urticaria—Calcitriol—psoriasis	0.00672	0.00672	CcSEcCtD
Methylscopolamine bromide—Somnolence—Acitretin—psoriasis	0.00669	0.00669	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisolone—psoriasis	0.00645	0.00645	CcSEcCtD
Methylscopolamine bromide—Constipation—Acitretin—psoriasis	0.00644	0.00644	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Mycophenolate mofetil—psoriasis	0.00633	0.00633	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Hydrocortisone—psoriasis	0.0063	0.0063	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methoxsalen—psoriasis	0.00628	0.00628	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Calcitriol—psoriasis	0.00624	0.00624	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Acitretin—psoriasis	0.00621	0.00621	CcSEcCtD
Methylscopolamine bromide—Asthenia—Calcitriol—psoriasis	0.00607	0.00607	CcSEcCtD
Methylscopolamine bromide—Urticaria—Acitretin—psoriasis	0.00598	0.00598	CcSEcCtD
Methylscopolamine bromide—Tension—Mycophenolic acid—psoriasis	0.00595	0.00595	CcSEcCtD
Methylscopolamine bromide—Headache—Methoxsalen—psoriasis	0.00595	0.00595	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Triamcinolone—psoriasis	0.00593	0.00593	CcSEcCtD
Methylscopolamine bromide—Nervousness—Mycophenolic acid—psoriasis	0.00589	0.00589	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Mycophenolic acid—psoriasis	0.00572	0.00572	CcSEcCtD
Methylscopolamine bromide—Nausea—Methoxsalen—psoriasis	0.00564	0.00564	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Acitretin—psoriasis	0.00555	0.00555	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Fluocinolone Acetonide—psoriasis	0.00553	0.00553	CcSEcCtD
Methylscopolamine bromide—Asthenia—Acitretin—psoriasis	0.0054	0.0054	CcSEcCtD
Methylscopolamine bromide—Vomiting—Calcitriol—psoriasis	0.00538	0.00538	CcSEcCtD
Methylscopolamine bromide—Palpitations—Mycophenolic acid—psoriasis	0.00536	0.00536	CcSEcCtD
Methylscopolamine bromide—Headache—Calcitriol—psoriasis	0.0053	0.0053	CcSEcCtD
Methylscopolamine bromide—Somnolence—Hydroxyurea—psoriasis	0.00526	0.00526	CcSEcCtD
Methylscopolamine bromide—Constipation—Hydroxyurea—psoriasis	0.00506	0.00506	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Mycophenolic acid—psoriasis	0.00505	0.00505	CcSEcCtD
Methylscopolamine bromide—Nausea—Calcitriol—psoriasis	0.00503	0.00503	CcSEcCtD
Methylscopolamine bromide—Confusional state—Mycophenolic acid—psoriasis	0.00499	0.00499	CcSEcCtD
Methylscopolamine bromide—Dizziness—Acitretin—psoriasis	0.00498	0.00498	CcSEcCtD
Methylscopolamine bromide—Dizziness—Fluocinolone Acetonide—psoriasis	0.00497	0.00497	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Hydroxyurea—psoriasis	0.00487	0.00487	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Mycophenolic acid—psoriasis	0.00483	0.00483	CcSEcCtD
Methylscopolamine bromide—Tension—Cyclosporine—psoriasis	0.00482	0.00482	CcSEcCtD
Methylscopolamine bromide—Vomiting—Acitretin—psoriasis	0.00479	0.00479	CcSEcCtD
Methylscopolamine bromide—Vomiting—Fluocinolone Acetonide—psoriasis	0.00477	0.00477	CcSEcCtD
Methylscopolamine bromide—Nervousness—Cyclosporine—psoriasis	0.00477	0.00477	CcSEcCtD
Methylscopolamine bromide—Headache—Acitretin—psoriasis	0.00472	0.00472	CcSEcCtD
Methylscopolamine bromide—Headache—Fluocinolone Acetonide—psoriasis	0.0047	0.0047	CcSEcCtD
Methylscopolamine bromide—Tension—Mycophenolate mofetil—psoriasis	0.0047	0.0047	CcSEcCtD
Methylscopolamine bromide—Abdominal distension—Prednisone—psoriasis	0.00469	0.00469	CcSEcCtD
Methylscopolamine bromide—Nervousness—Mycophenolate mofetil—psoriasis	0.00465	0.00465	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Cyclosporine—psoriasis	0.00463	0.00463	CcSEcCtD
Methylscopolamine bromide—Insomnia—Mycophenolic acid—psoriasis	0.00448	0.00448	CcSEcCtD
Methylscopolamine bromide—Nausea—Acitretin—psoriasis	0.00447	0.00447	CcSEcCtD
Methylscopolamine bromide—Nausea—Fluocinolone Acetonide—psoriasis	0.00446	0.00446	CcSEcCtD
Methylscopolamine bromide—Somnolence—Mycophenolic acid—psoriasis	0.0044	0.0044	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Hydroxyurea—psoriasis	0.00436	0.00436	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Prednisone—psoriasis	0.00429	0.00429	CcSEcCtD
Methylscopolamine bromide—Asthenia—Hydroxyurea—psoriasis	0.00424	0.00424	CcSEcCtD
Methylscopolamine bromide—Constipation—Mycophenolic acid—psoriasis	0.00423	0.00423	CcSEcCtD
Methylscopolamine bromide—Palpitations—Mycophenolate mofetil—psoriasis	0.00423	0.00423	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisolone—psoriasis	0.00421	0.00421	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Cyclosporine—psoriasis	0.00409	0.00409	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Mycophenolic acid—psoriasis	0.00408	0.00408	CcSEcCtD
Methylscopolamine bromide—Confusional state—Cyclosporine—psoriasis	0.00404	0.00404	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Cyclosporine—psoriasis	0.00401	0.00401	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Mycophenolate mofetil—psoriasis	0.00399	0.00399	CcSEcCtD
Methylscopolamine bromide—Confusional state—Mycophenolate mofetil—psoriasis	0.00394	0.00394	CcSEcCtD
Methylscopolamine bromide—Dizziness—Hydroxyurea—psoriasis	0.00391	0.00391	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Mycophenolate mofetil—psoriasis	0.00391	0.00391	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Mycophenolate mofetil—psoriasis	0.00381	0.00381	CcSEcCtD
Methylscopolamine bromide—Vomiting—Hydroxyurea—psoriasis	0.00376	0.00376	CcSEcCtD
Methylscopolamine bromide—Headache—Hydroxyurea—psoriasis	0.0037	0.0037	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisolone—psoriasis	0.00365	0.00365	CcSEcCtD
Methylscopolamine bromide—Insomnia—Cyclosporine—psoriasis	0.00362	0.00362	CcSEcCtD
Methylscopolamine bromide—Erectile dysfunction—Methotrexate—psoriasis	0.00359	0.00359	CcSEcCtD
Methylscopolamine bromide—Somnolence—Cyclosporine—psoriasis	0.00356	0.00356	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Hydrocortisone—psoriasis	0.00356	0.00356	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisolone—psoriasis	0.00356	0.00356	CcSEcCtD
Methylscopolamine bromide—Asthenia—Mycophenolic acid—psoriasis	0.00355	0.00355	CcSEcCtD
Methylscopolamine bromide—Insomnia—Mycophenolate mofetil—psoriasis	0.00353	0.00353	CcSEcCtD
Methylscopolamine bromide—Nausea—Hydroxyurea—psoriasis	0.00351	0.00351	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Hydrocortisone—psoriasis	0.00347	0.00347	CcSEcCtD
Methylscopolamine bromide—Somnolence—Mycophenolate mofetil—psoriasis	0.00347	0.00347	CcSEcCtD
Methylscopolamine bromide—Drowsiness—Methotrexate—psoriasis	0.00347	0.00347	CcSEcCtD
Methylscopolamine bromide—Constipation—Cyclosporine—psoriasis	0.00343	0.00343	CcSEcCtD
Methylscopolamine bromide—Dry mouth—Triamcinolone—psoriasis	0.00342	0.00342	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Triamcinolone—psoriasis	0.00335	0.00335	CcSEcCtD
Methylscopolamine bromide—Constipation—Mycophenolate mofetil—psoriasis	0.00334	0.00334	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Cyclosporine—psoriasis	0.0033	0.0033	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisolone—psoriasis	0.0033	0.0033	CcSEcCtD
Methylscopolamine bromide—Dizziness—Mycophenolic acid—psoriasis	0.00327	0.00327	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Triamcinolone—psoriasis	0.00327	0.00327	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Mycophenolate mofetil—psoriasis	0.00322	0.00322	CcSEcCtD
Methylscopolamine bromide—Insomnia—Hydrocortisone—psoriasis	0.00322	0.00322	CcSEcCtD
Methylscopolamine bromide—Urticaria—Cyclosporine—psoriasis	0.00318	0.00318	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mycophenolic acid—psoriasis	0.00315	0.00315	CcSEcCtD
Methylscopolamine bromide—Urticaria—Mycophenolate mofetil—psoriasis	0.0031	0.0031	CcSEcCtD
Methylscopolamine bromide—Headache—Mycophenolic acid—psoriasis	0.0031	0.0031	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Prednisone—psoriasis	0.00306	0.00306	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Dexamethasone—psoriasis	0.00304	0.00304	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Betamethasone—psoriasis	0.00304	0.00304	CcSEcCtD
Methylscopolamine bromide—Insomnia—Triamcinolone—psoriasis	0.00303	0.00303	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisolone—psoriasis	0.003	0.003	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Betamethasone—psoriasis	0.00297	0.00297	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Dexamethasone—psoriasis	0.00297	0.00297	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Cyclosporine—psoriasis	0.00295	0.00295	CcSEcCtD
Methylscopolamine bromide—Nausea—Mycophenolic acid—psoriasis	0.00294	0.00294	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Hydrocortisone—psoriasis	0.00293	0.00293	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisolone—psoriasis	0.0029	0.0029	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.00288	0.00288	CcSEcCtD
Methylscopolamine bromide—Asthenia—Cyclosporine—psoriasis	0.00287	0.00287	CcSEcCtD
Methylscopolamine bromide—Urticaria—Hydrocortisone—psoriasis	0.00283	0.00283	CcSEcCtD
Methylscopolamine bromide—Asthenia—Mycophenolate mofetil—psoriasis	0.0028	0.0028	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Triamcinolone—psoriasis	0.00276	0.00276	CcSEcCtD
Methylscopolamine bromide—Insomnia—Betamethasone—psoriasis	0.00275	0.00275	CcSEcCtD
Methylscopolamine bromide—Insomnia—Dexamethasone—psoriasis	0.00275	0.00275	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisolone—psoriasis	0.00269	0.00269	CcSEcCtD
Methylscopolamine bromide—Urticaria—Triamcinolone—psoriasis	0.00266	0.00266	CcSEcCtD
Methylscopolamine bromide—Dizziness—Cyclosporine—psoriasis	0.00265	0.00265	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Prednisone—psoriasis	0.00265	0.00265	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Hydrocortisone—psoriasis	0.00262	0.00262	CcSEcCtD
Methylscopolamine bromide—Tachycardia—Prednisone—psoriasis	0.00259	0.00259	CcSEcCtD
Methylscopolamine bromide—Dizziness—Mycophenolate mofetil—psoriasis	0.00258	0.00258	CcSEcCtD
Methylscopolamine bromide—Vision blurred—Methotrexate—psoriasis	0.00256	0.00256	CcSEcCtD
Methylscopolamine bromide—Asthenia—Hydrocortisone—psoriasis	0.00255	0.00255	CcSEcCtD
Methylscopolamine bromide—Vomiting—Cyclosporine—psoriasis	0.00255	0.00255	CcSEcCtD
Methylscopolamine bromide—Headache—Cyclosporine—psoriasis	0.00251	0.00251	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Dexamethasone—psoriasis	0.00251	0.00251	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Betamethasone—psoriasis	0.00251	0.00251	CcSEcCtD
Methylscopolamine bromide—Vomiting—Mycophenolate mofetil—psoriasis	0.00248	0.00248	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Triamcinolone—psoriasis	0.00247	0.00247	CcSEcCtD
Methylscopolamine bromide—Headache—Mycophenolate mofetil—psoriasis	0.00245	0.00245	CcSEcCtD
Methylscopolamine bromide—Urticaria—Dexamethasone—psoriasis	0.00242	0.00242	CcSEcCtD
Methylscopolamine bromide—Urticaria—Betamethasone—psoriasis	0.00242	0.00242	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisolone—psoriasis	0.00241	0.00241	CcSEcCtD
Methylscopolamine bromide—Asthenia—Triamcinolone—psoriasis	0.00241	0.00241	CcSEcCtD
Methylscopolamine bromide—Insomnia—Prednisone—psoriasis	0.0024	0.0024	CcSEcCtD
Methylscopolamine bromide—Nausea—Cyclosporine—psoriasis	0.00238	0.00238	CcSEcCtD
Methylscopolamine bromide—Dizziness—Hydrocortisone—psoriasis	0.00235	0.00235	CcSEcCtD
Methylscopolamine bromide—Nausea—Mycophenolate mofetil—psoriasis	0.00232	0.00232	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisolone—psoriasis	0.00228	0.00228	CcSEcCtD
Methylscopolamine bromide—Constipation—Prednisone—psoriasis	0.00227	0.00227	CcSEcCtD
Methylscopolamine bromide—Vomiting—Hydrocortisone—psoriasis	0.00226	0.00226	CcSEcCtD
Methylscopolamine bromide—Confusional state—Methotrexate—psoriasis	0.00223	0.00223	CcSEcCtD
Methylscopolamine bromide—Headache—Hydrocortisone—psoriasis	0.00223	0.00223	CcSEcCtD
Methylscopolamine bromide—Dizziness—Triamcinolone—psoriasis	0.00222	0.00222	CcSEcCtD
Methylscopolamine bromide—Anaphylactic shock—Methotrexate—psoriasis	0.00221	0.00221	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Prednisone—psoriasis	0.00218	0.00218	CcSEcCtD
Methylscopolamine bromide—Asthenia—Dexamethasone—psoriasis	0.00218	0.00218	CcSEcCtD
Methylscopolamine bromide—Asthenia—Betamethasone—psoriasis	0.00218	0.00218	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisolone—psoriasis	0.00217	0.00217	CcSEcCtD
Methylscopolamine bromide—Vomiting—Triamcinolone—psoriasis	0.00213	0.00213	CcSEcCtD
Methylscopolamine bromide—Nausea—Hydrocortisone—psoriasis	0.00211	0.00211	CcSEcCtD
Methylscopolamine bromide—Urticaria—Prednisone—psoriasis	0.0021	0.0021	CcSEcCtD
Methylscopolamine bromide—Headache—Triamcinolone—psoriasis	0.0021	0.0021	CcSEcCtD
Methylscopolamine bromide—Dizziness—Dexamethasone—psoriasis	0.00201	0.00201	CcSEcCtD
Methylscopolamine bromide—Dizziness—Betamethasone—psoriasis	0.00201	0.00201	CcSEcCtD
Methylscopolamine bromide—Insomnia—Methotrexate—psoriasis	0.002	0.002	CcSEcCtD
Methylscopolamine bromide—Nausea—Triamcinolone—psoriasis	0.00199	0.00199	CcSEcCtD
Methylscopolamine bromide—Somnolence—Methotrexate—psoriasis	0.00197	0.00197	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Prednisone—psoriasis	0.00195	0.00195	CcSEcCtD
Methylscopolamine bromide—Vomiting—Betamethasone—psoriasis	0.00193	0.00193	CcSEcCtD
Methylscopolamine bromide—Vomiting—Dexamethasone—psoriasis	0.00193	0.00193	CcSEcCtD
Methylscopolamine bromide—Headache—Betamethasone—psoriasis	0.00191	0.00191	CcSEcCtD
Methylscopolamine bromide—Headache—Dexamethasone—psoriasis	0.00191	0.00191	CcSEcCtD
Methylscopolamine bromide—Asthenia—Prednisone—psoriasis	0.0019	0.0019	CcSEcCtD
Methylscopolamine bromide—Feeling abnormal—Methotrexate—psoriasis	0.00182	0.00182	CcSEcCtD
Methylscopolamine bromide—Nausea—Dexamethasone—psoriasis	0.00181	0.00181	CcSEcCtD
Methylscopolamine bromide—Nausea—Betamethasone—psoriasis	0.00181	0.00181	CcSEcCtD
Methylscopolamine bromide—Urticaria—Methotrexate—psoriasis	0.00176	0.00176	CcSEcCtD
Methylscopolamine bromide—Dizziness—Prednisone—psoriasis	0.00175	0.00175	CcSEcCtD
Methylscopolamine bromide—Vomiting—Prednisone—psoriasis	0.00168	0.00168	CcSEcCtD
Methylscopolamine bromide—Headache—Prednisone—psoriasis	0.00166	0.00166	CcSEcCtD
Methylscopolamine bromide—Hypersensitivity—Methotrexate—psoriasis	0.00163	0.00163	CcSEcCtD
Methylscopolamine bromide—Asthenia—Methotrexate—psoriasis	0.00159	0.00159	CcSEcCtD
Methylscopolamine bromide—Nausea—Prednisone—psoriasis	0.00157	0.00157	CcSEcCtD
Methylscopolamine bromide—Dizziness—Methotrexate—psoriasis	0.00146	0.00146	CcSEcCtD
Methylscopolamine bromide—Vomiting—Methotrexate—psoriasis	0.00141	0.00141	CcSEcCtD
Methylscopolamine bromide—Headache—Methotrexate—psoriasis	0.00139	0.00139	CcSEcCtD
Methylscopolamine bromide—Nausea—Methotrexate—psoriasis	0.00131	0.00131	CcSEcCtD
